Vaccine-Related Journal Articles

Anthrax		HPV		Pertussis		Rubella
Chickenpox (varicella)		Influenza (variant)		PCV		Shingles (zoster)
Diphtheria		Influenza (seasonal)		PPSV		Smallpox
Hepatitis A		Measles		Polio		Tetanus
Hepatitis B		Meningococcus		Rabies
Hib		Mumps		Rotavirus

PCV archive 2003-1998

Pneumococcal conjugate vaccine (PCV) 2013

Near Complete Elimination of the Seven Valent Pneumococcal Conjugate Vaccine Serotypes in Tennessee Authors: asa NB, Grijalva CG, Arbogast PG, Talbot TR, Craig AS, Griffin MR, Schaffner W Source: Pediatr Infect Dis J, January 23, 2013

Abstract

back to top

Pneumococcal conjugate vaccine (PCV) 2012

Epidemiology of Invasive Pneumococcal Disease among High-Risk Adults since the Introduction of Pneumococcal Conjugate Vaccine for Children Authors: Muhammad RD, Oza-Frank R, Zell E, et al. Source: Clin Infect Dis, December 18, 2012

Abstract

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Source: MMWR, October 12, 2012, Vol. 61(40):816-19

HTML

The 13-Valent Pneumococcal Conjugate Vaccine for Invasive Pneumococcal Disease in Alaska Native Children: Results of a Clinical Trial Authors: Singleton R, Wenger J, Klejka JA, et al. Source: Pediatr Infect Dis J, September 20, 2012

Abstract

National, State, and Local Area Vaccination Coverage Among Children Aged 19–35 Months--United States, 2011 Source: MMWR, September 7, 2012, Vol. 61(35):689-96

HTML

Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older Source: MMWR, June 1, 2102, Vol. 61(21):394-5

HTML

back to top

Pneumococcal conjugate vaccine (PCV) 2011

Invasive Pneumococcal Disease and 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Coverage among Children Aged ≤59 Months--Selected U.S. Regions, 2010-2011 Source: MMWR, November 4, 2011, Vol. 60(43):1477-81

HTML

National and State Vaccination Coverage among Children Aged 19-35 Months--United States, 2010 Source: MMWR, September 2, 2011, Vol. 60(34):1157-63

HTML

County-Level Trends in Vaccination Coverage among Children Aged 19-35 Months--United States, 1995-2008 Source: MMWR, April 29, 2011, Vol. 60(SS-04):1-86

HTML

back to top

Pneumococcal conjugate vaccine (PCV) 2010

Prevention of Pneumococcal Disease among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Source: MMWR Recommendations and Reports, December 10, 2010, Vol. 59(RR-11)

PDF

Parental Decline of Pneumococcal Vaccination and Risk of Pneumococcal Related Disease in Children Authors: Glanz JM, McClure DL, O'Leary ST, et al. Source: Vaccine, December 8, 2010

Abstract

National, State, and Local Area Vaccination Coverage among Children Aged 19--35 Months--United States, 2009 Source: MMWR, September 17, 2010, Vol. 59(36):1171-7

HTML

Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Infants and Toddlers Authors: Yeh SH, Gurtman A, Hurley DC, et al. Source: Pediatrics, August 23, 2010

Abstract

Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Authors: Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA; PCV13 Infant Study Group Source: Pediatrics, May 2010, Vol. 25(5):866-75

Abstract

Invasive Pneumococcal Disease in Young Children before Licensure of 13-Valent Pneumococcal Conjugate Vaccine--United States, 2007 Source: MMWR, March 12, 2010, Vol. 59(09):253-6

HTML

Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children--Advisory Committee on Immunization Practices (ACIP), 2010 Source: MMWR, March 12, 2010, Vol. 59(09):258-61

HTML

Invasive Pneumococcal Infections among Vaccinated Children in the United States Authors: Park SY, Van Beneden CA, Pilishvili T, et al. Source: J Pediatr, March 2010, Vol. 156(3):478-483.e2

Abstract

back to top

Pneumococcal conjugate vaccine (PCV) 2009

The Effect of Routine Vaccination on Invasive Pneumococcal Infections in Canadian Children, Immunization Monitoring Program, Active 2000-2007 Authors: Bettinger JA, Scheifele DW, Kellner JD, et al. Source: Vaccine, December 28, 2009

Abstract

Invasive Pneumococcal Infections among Vaccinated Children in the United States Authors: Park SY, Van Beneden CA, Pilishvili T, et al. Source: J Pediatr, December 2, 2009

Abstract

Cost-Effectiveness of a 3-Dose Pneumococcal Conjugate Vaccine Program in the Province of Quebec, Canada Authors: Poirier B, De Wals P, Petit G, Erickson LJ, Pépin J Source: Vaccine, September 25, 2009

Abstract

Immunization Programs for Infants, Children, Adolescents, and Adults: Clinical Practice Guidelines by the Infectious Diseases Society of America Authors: Pickering LK, Baker CJ, Freed GL, et al. Source: Clin Infect Dis, September 15, 2009, Vol. 49(6):817-40

Abstract

National, State, and Local Area Vaccination Coverage among Children Aged 19-35 Months--United States, 2008 Source: MMWR, August 28, 2009, Vol. 58(33):921-6

HTML

Immunization with the 7-Valent Conjugate Pneumococcal Vaccine: Impact Evaluation, Continuing Surveillance and Future Perspectives Authors: Bechini A, Boccalini S, Bonanni P Source: Vaccine, February 5, 2009

Abstract

Pneumonia Hospitalizations among Young Children Before and after Introduction of Pneumococcal Conjugate Vaccine--United States, 1997-2006 Source: MMWR, January 16, 2009, Vol. 58(01):1-4

HTML  |  PDF (entire issue)

back to top

Pneumococcal conjugate vaccine (PCV) 2008

Decreases in Case-Fatality and Mortality Rates for Invasive Pneumococcal Disease in Olmsted County, Minnesota, during 1995-2007: A Population-Based Study Authors: Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM Source: Clin Infect Dis, December 1, 2008, Vol. 47(11):1367-71

Abstract

Temporary Vaccine Recommendations and Provider Compliance: A Survey of Pediatric Practices during the 2003-2004 Pneumococcal Conjugate Vaccine Shortage Authors: Groom H, Bhatt A, Washington ML, Santoli J Source: Pediatrics, October 2008, Vol. 122(4):e835-40

Abstract

Indirect Effect of 7-valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household Members Authors: Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL Source: Clin Infect Dis, October 15, 2008, Vol. 47(8):989-96

Abstract

Impact of the Introduction of Pneumococcal Conjugate Vaccine on Rates of Community Acquired Pneumonia in Children and Adults Authors: Nelson JC, Jackson M, Yu O, et al. Source: Vaccine, September 8, 2008, Vol. 26(38):4947-54

Abstract

Changing Epidemiology of Invasive Pneumococcal Disease among White Mountain Apache Persons in the Era of the Pneumococcal Conjugate Vaccine Authors: Lacapa R, Bliss SJ, Larzelere-Hinton F, et al. Source: Clin Infect Dis, August 15, 2008, Vol. 47(4):476-84

Abstract

Immunogenicity and Safety of an Inactivated Hepatitis A Vaccine Administered Concomitantly with a Pneumococcal Conjugate Vaccine in Healthy Children 15 Months of Age Authors: Trofa AF, Levin M, Marchant CD, Hedrick J, Blatter MM Source: Pediatr Infect Dis J, July 2008, Vol. 27(7):658-60

Abstract

Changing Epidemiology of Pneumococcal Meningitis after the Introduction of Pneumococcal Conjugate Vaccine in the United States Authors: Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG Source: Clin Infect Dis, June 1, 2008, Vol. 46(11):1664-72

Abstract

Safety Profile of Pneumococcal Conjugate Vaccines: Systematic Review of Pre- and Post-Licensure Data Authors: Destefano F, Pfeifer D, Nohynek H Source: Bull World Health Organ, May 2008, Vol. 86(5):373-80

Abstract

The Changing Epidemiology of Pneumococcal Pulmonary Disease in the Era of the Heptavalent Vaccine Author: Lexau CA Source: Curr Infect Dis Rep, May 2008, Vol. 10(3):229-35

Abstract

Impact of Conjugate Vaccine on Transmission of Antimicrobial-Resistant Streptococcus pneumoniae among Alaskan Children Authors: Park SY, Moore MR, Bruden DL, et al. Source: Pediatr Infect Dis J, April 2008, Vol. 27(4):335-40

Abstract

Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24-59 Months Who Are Not Completely Vaccinated Source: MMWR, April 4, 2008, Vol. 57(13):343-4

HTML  |  PDF (entire issue)

Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Children with Sickle Cell Disease in the First Decade of Life Authors: Adamkiewicz TV, Silk BJ, Howgate J, Baughman W, Strayhorn G, Sullivan K, Farley MM Source: Pediatrics, March 2008, Vol. 121(3):562-9

Abstract

The Impact of Indirect (Herd) Protection on the Cost-Effectiveness of Pneumococcal Conjugate Vaccine Authors: Isaacman DJ, Strutton DR, Kalpas EA, et al. Source: Clin Ther, February 2008, Vol. 30(2):341-57

Abstract

Population-Based Impact of Routine Infant Immunization with Pneumococcal Conjugate Vaccine in the USA Authors: Grijalva CG, Griffin MR Source: Expert Rev Vaccines, February 2008, Vol. 7(1):83-95

Abstract

Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997-2004 Authors: Zhou F, Shefer A, Kong Y, Nuorti JP Source: Pediatrics, February 2008, Vol. 121(2):253-60

Abstract

Invasive Pneumococcal Disease in Children 5 Years after Conjugate Vaccine Introduction--Eight States, 1998—2005 Author: Centers for Disease Control and Prevention Source: MMWR, February 15, 2008, Vol. 57(06):144-8

HTML  |  PDF (entire issue)

Randomized, Controlled Trial Efficacy of Pneumococcal Conjugate Vaccine against Otitis Media among Navajo and White Mountain Apache Infants Source: Pediatr Infect Dis J, January 2008, Vol. 27(1):71-3

Abstract

Uptake of Pneumococcal Conjugate Vaccine among Children in the 1998-2002 United States Birth Cohorts Authors: Nuorti JP, Martin SW, Smith PJ, Moran JS, Schwartz B Source: Am J Prev Med, January 2008, Vol. 34(1):46-53

Abstract

back to top

Pneumococcal conjugate vaccine (PCV) 2007

Surveillance for Invasive Pneumococcal Disease During 2000-2005 in a Population of Children Who Received 7-Valent Pneumococcal Conjugate Vaccine Authors: Black S, France EK, Isaacman D, et al Source: Pediatr Infect Dis J, September 2007; 26(9):771-777

Abstract

National, State, and Local Area Vaccination Coverage among Children Aged 19-35 Months--United States, 2006 Source: MMWR, August 31, 2007; 56(34):880-885

HTML  |  PDF (entire issue)

Changing Characteristics of Invasive Pneumococcal Disease in Metropolitan Atlanta, Georgia, after Introduction of a 7-Valent Pneumococcal Conjugate Vaccine Authors: Albrich WC, Baughman W, Schmotzer B, Farley MM Source: Clin Infect Dis, June 15, 2007; 44(12):1569-1576

Abstract

Pneumococcal Bacteremia in Febrile Infants Presenting to the Emergency Department before and after the Introduction of the Heptavalent Pneumococcal Vaccine Authors: Carstairs KL, Tanen DA, Johnson AS, Kailes SB, Riffenburgh RH Source: Ann Emerg Med, June 2007; 49(6):772-777

Abstract

Emergence of 19A as Virulent and Multidrug Resistant Pneumococcus in Massachusetts Following Universal Immunization of Infants With Pneumococcal Conjugate Vaccine Authors: Pelton SI, Huot H, Finkelstein JA, et al Source: Pediatr Infect Dis J, June 2007; 26:468-472

Abstract

Resurgence of the Multiresistant Pneumococcus (commentary) Authors: Klugman KP, McGee L Source: Pediatr Infect Dis J, June 2007; 26(6):473

Abstract

Impact of the Pneumococcal Conjugate Vaccine on Serotype Distribution and Antimicrobial Resistance of Invasive Streptococcus pneumoniae Isolates in Dallas, TX, Children from 1999 through 2005 Authors: Messina AF, Katz-Gaynor K, Barton T, et al Source: Pediatr Infect Dis J, June 2007; 26(6):461-467

Abstract

Effectiveness of Pneumococcal Conjugate Vaccine in Greater Vancouver, Canada: 2004-2005 Authors: Bjornson G, Scheifele DW, Bettinger J, et al Source: Pediatr Infect Dis J, June 2007; 26(6):540-542

Abstract

Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes among Alaska Native Children with High Levels of 7-Valent Pneumococcal Conjugate Vaccine Coverage Authors: Singleton RJ, Hennessy TW, Bulkow LR, et al Source: JAMA, April 25, 2007; 297(16):1784-1792

Abstract

Editorial: Invasive Pneumococcal Disease - The Target Is Moving Authors: Peters TR, Poehling KA Source: JAMA, April 25, 2007; 297(16):1825-1827

Abstract

WHO Position Paper: Pneumococcal Conjugate Vaccine for Childhood Immunization Source: Weekly Epidemiological Record, March 23, 2007; 82(12): 93-104

PDF

Cost-effectiveness of Pneumococcal Conjugate Vaccination in the Prevention of Child Mortality: An international economic analysis Authors: Sinha A, Levine O, Knoll MD, et al Source: Lancet, February 3, 2007; 369:389-396

Abstract

back to top

Pneumococcal conjugate vaccine (PCV) 2006

General Recommendations on Immunization Source: MMWR, December 1, 2006; 55(RR-15):1-48

HTML |  PDF (entire issue)

Effectiveness of Seven-Valent Pneumococcal Conjugate Vaccine against Invasive Pneumococcal Disease: A Matched Case-Control Study Authors: Whitney CG, Pilishvili T, Farley MM, et al Source: Lancet, October 28, 2006; 368(9546):1495-1502

Abstract

The Impact of Conjugate Pneumococcal Vaccination on Routine Childhood Vaccination and Primary Care Use in 2 Counties Authors: Szilagyi PG, Griffin MR, Shone LP, et al Source: Pediatrics, October 2006, Vol. 118(4):1394-1402

Abstract

Cost-effectiveness of Pneumococcal Conjugate Vaccine: Evidence from the First 5 Years of Use in the United States Incorporating Herd Effects Authors: Ray GT, Whitney CG, Fireman BH, et al Source: Pediatr Infect Dis J, June 2006, Vol. 25(6):494-501

Abstract

Indirect Effect of Conjugate Vaccine on Adult Carriage of Streptococcus Pneumoniae: An Explanation of Trends in Invasive Pneumococcal Disease Authors: Hammitt LL, Bruden DL, Butler JC, et al Source: J Infect Dis, June 1, 2006, Vol. 193(11):1487-1494

Abstract

Impact of State Vaccine Financing Policy on Uptake of Heptavalent Pneumococcal Conjugate Vaccine Authors: Stokley S, Shaw KM, Barker L, Santoli JM, Shefer A Source: Am J Public Health, May 30, 2006 [Epub ahead of print]

Abstract

Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Bacterial Colonization During Acute Otitis Media Authors: Revai K, McCormick DP, Patel J, et al Source: Pediatrics, May 2006, Vol. 117(5):1823-1829

Abstract

Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate Vaccine Authors: Poehling KA, Talbot TR, Griffin MR, et al Source: JAMA, April 12, 2006, Vol. 295(14):1668-1674

Abstract

Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-resistant Streptococcus pneumoniae Authors: Kyaw MH, Lynfield R, Schaffner W, et al Source: N Engl J Med, April 6, 2006, Vol. 354(14):1455-1463

Abstract

Emergence of Vaccine-Related Pneumococcal Serotypes as a Cause of Bacteremia Authors: Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Source: Clin Infect Dis, April 1, 2006, Vol. 42(7):907-914

Abstract

Immunogenicity, Reactogenicity and Safety of a 7-valent Pneumococcal Conjugate Vaccine (PCV7) Concurrently Administered with a DTPa-HBV-IPV/Hib Combination Vaccine in Healthy Infants Authors: Knuf M, Habermehl P, Cimino C, et al Source: Vaccine, March 24, 2006, [Epub ahead of print]

Abstract

Tailoring the Strategies to Specific Shortages: Pneumococcal Conjugate Vaccine Author: Peter G Source: Clin Infect Dis, March 1, 2006, Vol. 42 (Suppl 3):S138-S140

Abstract

back to top

Pneumococcal conjugate vaccine (PCV) 2005

Changing Epidemiology of Invasive Pneumococcal Disease Among Older Adults in the Era of Pediatric Pneumococcal Conjugate Vaccine Authors: Lexau CA, Lynfield R, Danila R, et al Source: JAMA, Oct. 26, 2005, Vol. 294(16):2043-2051

Abstract

Impact of Conjugate Pneumococcal Vaccines Author: Whitney CG Source: Pediatr Infect Dis J, August 2005, Vol. 24(8):729-730

Abstract

Who's Calling the Shots? Pediatricians' Adherence to the 2001-2003 Pneumococcal Conjugate Vaccine-Shortage Recommendations Authors: Broder KR, MacNeil A, Malone S Source: Pediatrics, June 2005, Vol. 115(6):1479-1487

Abstract

Accuracy of Adult Reported Pneumococcal Vaccination Status of Children Authors: Czaja C, Crossette L, Metlay JP Source: Ann Epidemiol, April 2005, Vol. 15(4):253-256

Abstract

Comparison of Incidence of Invasive Streptococcus Pneumoniae Disease Among Children Before and After Introduction of Conjugated Pneumococcal Vaccine Authors: Haddy RI, Perry K, Chacko CE, et al Source: Pediatr Infect Dis J, April 2005, Vol. 24(4):320-323

Abstract

Effect of Pneumococcal Vaccination on Quality of Life in Children with Recurrent Acute Otitis Media: A Randomized, Controlled Trial Authors: Brouwer CN, Maille AR, Rovers MM, et al Source: Pediatrics, Feb. 2005, Vol. 115(2):273-279

Abstract

Population-Based Surveillance for Childhood Invasive Pneumococcal Disease in the Era of Conjugate Vaccine Authors: Hsu K, Pelton S, Karumuri S, et al Source: Pediatr Infect Dis J, January 2005, Vol. 24(1):17-23

Abstract

back to top

Pneumococcal conjugate vaccine (PCV) 2004

Postlicensure Safety Surveillance for 7-valent Pneumococcal Conjugate Vaccine Authors: Wise RP, Iskander J, Pratt RD, et al Source: JAMA, October 13, 2004, Vol. 292(14):1702-1710

Abstract

Population-Based Impact of Pneumococcal Conjugate Vaccine in Young Children Authors: Poehling KA, Lafleur BJ, Szilagyi PG, Edwards KM, Mitchel E, Barth R, Schwartz B, Griffin MR Source: Pediatrics, September 2004, Vol. 114(3):755-761

Abstract

Cost-effectiveness Studies of Pneumococcal Conjugate Vaccines Author: McIntosh ED Source: Expert Rev Vaccines, August 2004, Vol. 3(4):433-442

Abstract

The Seven-Valent Pneumococcal Conjugate Vaccine Reduces Tympanostomy Tube Placement in Children Authors: Palmu AA, Verho J, Jokinen J, et al Source: Pediatr Infect Dis J, August 2004, Vol. 23(8):732-738

Abstract

Elimination of Racial Differences in Invasive Pneumococcal Disease in Young Children After Introduction of the Conjugate Pneumococcal Vaccine Authors: Talbot TR, Poehling KA, Hartert TV, et al Source: Pediatr Infect Dis J, August 2004, Vol. 23(8):726-731

Abstract

Pediatricians' Self-Reported Clinical Practices and Adherence to National Immunization Guidelines After the Introduction of Pneumococcal Conjugate Vaccine Authors: Lee KC, Finkelstein JA, Miroshnik IL, et al. Source: Archives of Pediatric and Adolescent Medicine, July 2004, Vol. 158(7):695-701

Abstract

Pneumococcal Vaccines: Do They Prevent Infection and How? Authors: Posfay-Barbe KM, Wald ER Source: Curr Opin Infect Dis, June 2004, Vol. 17(3):177-184

Abstract

Postlicensure Surveillance for Pneumococcal Invasive Disease After Use of Heptavalent Pneumococcal Conjugate Vaccine in Northern California Kaiser Permanente Authors: Black S, Shinefield H, Baxter R, et al Source: Pediatr Infect Dis J, June 2004, Vol. 23(6):485-489

Abstract

Impact of PCV7 on Invasive Pneumococcal Disease Among Children Younger than 5 Years: A Population-Based Study Authors: Ramani RR, Hall WN, Boulton M, Johnson DR, Zhu Bao-Ping Source: American Journal of Public Health

Abstract

Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus Pneumoniae Infections Authors: Flannery B, Schrag S, Bennett NM, et al Source: JAMA, May 12, 2004, Vol. 291(18):2197-2203

Abstract

Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases Authors: O'Brien KL, Santosham M Source: Am J Epidemiol, April 1, 2004, Vol. 159(7):634-644

Abstract

Review of Pneumococcal Conjugate Vaccine in Adults: Implications on Clinical Development Author: Abraham-Van Parijs B Source: Vaccine, March 29, 2004, Vol. 22(11-12):1362-1371

Abstract

Notice to Readers: Updated Recommendations on the Use of Pneumococcal Conjugate Vaccine: Suspension of Recommendation for Third and Fourth Dose Source: MMWR, March 5, 2004, Vol. 53(8):177-178

HTML

Decrease of Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States After the Introduction of the 7-valent Pneumococcal Conjugate Vaccine Authors: Kaplan SL, et al Source: Pediatrics, March 2004, Vol. 113(3 Pt 1):443-449

Abstract

Notice to Readers: Limited Supply of Pneumococcal Conjugate Vaccine: Suspension of Recommendation for Fourth Dose Source: MMWR, February 13, 2004, Vol. 53(05):108-109

HTML

back to top

Pneumococcal conjugate vaccine (PCV) Archive

PCV journal articles 2003-1998